Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy with Sodium Zirconium Cyclosilicate in Heart Failure

Trial Identifier: D9484C00001
Sponsor: AstraZeneca
NCTID:: NCT03532009
Start Date: June 2018
Primary Completion Date: May 2020
Study Completion Date: May 2020
Condition: Congestive Heart Failure

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations